SCHEMBL25538402

SCHEMBL25538402

CC1(C)c2cc3ccccc3cc2-c2cccc(-c3ccc(-c4cc(-c5cccc6ccccc56)nc(-c5cccc6ccccc56)n4)c4ccccc34)c21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HTR2C P28335 4/20 0.36
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
HTR2A P28223 1/20 0.33
PIM1 P11309 1/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25540484 1.00 MEN1 (0.37) MEN1KMT2AHTR2CKDM4EALDH1A1
SCHEMBL25540326 0.94 MEN1 (0.36) MEN1KMT2AHTR2CKDM4EALDH1A1
SCHEMBL25539690 0.94 MEN1 (0.36) MEN1KMT2AHTR2CKDM4EALDH1A1
SCHEMBL25538398 0.94 MEN1 (0.36) MEN1KMT2AHTR2CKDM4EALDH1A1
SCHEMBL25540483 0.93 MEN1 (0.36) MEN1KMT2AHTR2CKDM4EALDH1A1
SCHEMBL25538401 0.93 MEN1 (0.36) MEN1KMT2AHTR2CKDM4EALDH1A1
SCHEMBL25538403 0.92 PIM1 (0.45) MEN1KMT2AHTR2CPIM1TUBB4A
SCHEMBL25538399 0.92 PIM1 (0.35) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL25537882 0.91 ALDH1A1 (0.40) MEN1KMT2AHTR2CKDM4EALDH1A1
SCHEMBL25537170 0.91 ALDH1A1 (0.40) MEN1KMT2AHTR2CKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM MEN1 267/4885KMT2A 1094/4885HTR2C 4636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.